Board Member
Eloxx Pharmaceuticals, Inc. (ELOX)Equibles does not estimate personal net worth.
Get an email with a short summary when Eloxx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELOX alertsSumit Aggarwal is recorded as CEO and Board Member at Eloxx Pharmaceuticals, Inc. (ELOX). The newest filing on record that lists Sumit Aggarwal as CEO and Board Member at Eloxx Pharmaceuticals, Inc. (ELOX) is dated April 28, 2023. Sumit Aggarwal has spoken on 1 investor event across 1 company, most recently for Eloxx Pharmaceuticals, Inc. on November 9, 2026. Eloxx Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eloxx Pharmaceuticals, Inc. includes Daniel Geffken (CFO and Chief Accounting Officer), Gary D. Rakers (CFO), Neil S. Belloff (COO) and 7 others.
“So, you know, we've been public now for almost eight years when we went through. A bit of a cathartic time three years ago, but last, in June, we raised money to prosecute both our programs.”
Start not stated–present
Last confirmed April 28, 2023
Start not stated–present
Last confirmed April 28, 2023
Biotechnology · Healthcare
CEO, Board Member
